Benjamin Shaver's questions to Pediatrix Medical Group Inc (MD) leadership • Q4 2024
Question
Benjamin Shaver asked for a breakdown of the Q4 pricing strength, the timing of the EBITDA benefit from portfolio restructuring, and the company's plans for capital allocation given its strong cash position.
Answer
CFO Kasandra Rossi noted that hospital admin fees were just under a third of the pricing component and that about one-third of the $30M restructuring EBITDA benefit was realized in 2024, with the rest to come in 2025. CEO Mark Ordan stated that a strong balance sheet is a priority in turbulent times and that the board will determine the best use of cash as the year progresses.